Mefloquine for preventing malaria in pregnant women Unchanged
Mefloquine for preventing malaria in pregnant women Unchanged is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mefloquine for Preventing Malaria in Pregnant Women Unchanged." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438868/all/Mefloquine_for_preventing_malaria_in_pregnant_women_Unchanged. Accessed 01 July 2022.
Mefloquine for preventing malaria in pregnant women Unchanged. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438868/all/Mefloquine_for_preventing_malaria_in_pregnant_women_Unchanged. Accessed July 1, 2022.
Mefloquine for preventing malaria in pregnant women Unchanged. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438868/all/Mefloquine_for_preventing_malaria_in_pregnant_women_Unchanged
Mefloquine for Preventing Malaria in Pregnant Women Unchanged [Internet]. In: Cochrane Abstracts. [cited 2022 July 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438868/all/Mefloquine_for_preventing_malaria_in_pregnant_women_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mefloquine for preventing malaria in pregnant women Unchanged
ID - 438868
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438868/all/Mefloquine_for_preventing_malaria_in_pregnant_women_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -